| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N05AL03 |
| UNII: | LAH70H9JPH |
| InChI Key | JTVPZMFULRWINT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H24N2O4S |
| Molecular Weight | 328.43 |
| AlogP | 1.17 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 75.71 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 22.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 3.198 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -4.78-5.83 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | 2078 | - | 779 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | 1149 | - | 390 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Tourette Syndrome | 3 | D005879 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 51012-32-9 |
| ChEBI | 94666 |
| ChEMBL | CHEMBL84158 |
| DrugBank | DB13025 |
| DrugCentral | 2651 |
| EPA CompTox | DTXSID0023664 |
| FDA SRS | LAH70H9JPH |
| Human Metabolome Database | HMDB0042039 |
| PubChem | 5467 |
| SureChEMBL | SCHEMBL34750 |
| ZINC | ZINC000001542927 |